Sleep Apnea Clinical Trial
Official title:
Validation of a Contactless Sensor for Sleep Apnea Diagnosis Against Polysomnography
Verified date | January 2022 |
Source | Sleepiz AG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies. Patients who are prescribed polysomnography study will be asked to participate and undergo a simultaneous sleep recording with radar sensor-based device.
Status | Completed |
Enrollment | 116 |
Est. completion date | December 21, 2021 |
Est. primary completion date | December 21, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age >18years - Ability and consent to undergo electrophysiological routine assessment - Patients suspected to suffer from sleep apnea or any other sleep related disorder Exclusion Criteria: - Previous enrollment into the current study, - Enrollment of the investigator, his/her family members and other dependent persons - Cardiac pacemaker or another implanted electrical device - Women who are pregnant or breastfeeding - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant |
Country | Name | City | State |
---|---|---|---|
Germany | Universitätsmedizin Essen Ruhrlandklinik | Essen | North Rhine-Westphalia |
Lead Sponsor | Collaborator |
---|---|
Sleepiz AG |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Binary classification of subjects based on their sleep apnea severity (AHI == 15) made by Sleepiz One+, compared to PSG data manually scored by sleep technicians | 1 Night |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Recruiting |
NCT03919955 -
A Novel Pharmacological Therapy for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT03927547 -
Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders
|
N/A | |
Recruiting |
NCT04007380 -
Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI
|
N/A | |
Completed |
NCT02188498 -
Electrocardiography Data Analysis in Sleep Disorders
|
||
Completed |
NCT01503164 -
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
|
N/A | |
Recruiting |
NCT00747890 -
Surgical Treatment of Mild Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT00738179 -
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
|
Phase 3 | |
Completed |
NCT00841906 -
Alice PDx User/Validation Extended Trial
|
N/A | |
Completed |
NCT00202501 -
Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome
|
N/A | |
Completed |
NCT00047463 -
Effects of Treating Obstructive Sleep Apnea in Epilepsy
|
Phase 2 | |
Not yet recruiting |
NCT06029881 -
Portable System for Non-intrusive Monitoring of Sleep
|
||
Recruiting |
NCT06093347 -
Central Apnoea Monitor Study
|
||
Terminated |
NCT05445869 -
Severe OSA Study (SOS)
|
N/A | |
Withdrawn |
NCT04096261 -
The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
|
||
Recruiting |
NCT04575740 -
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea
|
N/A | |
Completed |
NCT04676191 -
Validation of a Contactless Vital Signs Measurement Sensor
|
N/A | |
Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
Completed |
NCT06051097 -
Metabolic Syndrome and Obstructive Sleep Apnea
|
||
Completed |
NCT05687097 -
Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
|